AstraZeneca, Lilly to deepen collaboration on cancer immunotherapy

October 22, 2015 6:33 AM

31 0

LONDON Oct 22 AstraZeneca and Eli Lilly said on Thursday they were deepening their collaboration in cancer immunotherapy by testing new drug combinations for treating solid tumours.

Lilly will lead the studies, while both companies will contribute resources. Details of financial arrangements and tumours to be studied were not disclosed.

Also read: UnitedHealth and Morgan Stanley climb while Impax skids

Read more

To category page